<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35369482</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>A Single Amino Acid Substitution in Structural Protein VP2 Abrogates the Neurotropism of Enterovirus A-71 in Mice.</ArticleTitle><Pagination><StartPage>821976</StartPage><MedlinePgn>821976</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">821976</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2022.821976</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-A71) causes hand, foot, and mouth disease (HFMD) in children and has been associated with neurological complications. With no specific treatment and a monovalent vaccine limited to the Chinese market, HFMD remains a serious public health concern and an economic burden to affected societies. The molecular mechanisms underpinning EV-A71 neurovirulence have yet to be fully elucidated. In this work, we provide experimental evidence that a single amino acid substitution (I to K) at position 149 in structural protein VP2 of a non-mouse-adapted EV-A71 strain completely and specifically abrogated its infectivity in murine motor neuron-like NSC-34 cells. We showed that VP2 I149K mutant was impaired in murine SCARB2-mediated entry step but retained the ability to attach at the cell surface. <i>In vivo</i>, VP2 I149K mutant was fully attenuated in a symptomatic mouse model of progressive limb paralysis. While viral titers in limb muscles were comparable to mice infected with parental wild-type strain, significantly lower viral titers were measured in the spinal cord and brain, with minimal tissue damage, therefore indicating that VP2 I149K mutant is specifically impaired in its ability to invade the central nervous system (CNS). This study highlights the key role of amino acid at position 149 in VP2 in EV-A71 neurovirulence, and lends further support that the EF loop of VP2 represents a potential therapeutic target.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Yeo, Chong, Chen, Lim, Ng, Yan, Chu, Chow and Alonso.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Connie Wan Hui</ForeName><Initials>CWH</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Elijah Weihua</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ze Qin</ForeName><Initials>ZQ</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Qing Yong</ForeName><Initials>QY</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Benedict</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Molecular Diagnosis Centre, National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Justin Jang Hann</ForeName><Initials>JJH</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Vincent T K</ForeName><Initials>VTK</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SCARB2</Keyword><Keyword MajorTopicYN="N">VP2 EF loop</Keyword><Keyword MajorTopicYN="N">enterovirus A-71</Keyword><Keyword MajorTopicYN="N">foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">neurovirulence</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35369482</ArticleId><ArticleId IdType="pmc">PMC8969769</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2022.821976</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bian L., Wang Y., Yao X., Mao Q., Xu M., Liang Z. (2015). Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev. Anti Infect. Ther. 13 1061&#x2013;1071. 10.1586/14787210.2015.1058156</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2015.1058156</ArticleId><ArticleId IdType="pubmed">26112307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J. H., Law C. K., Hamblion E., Fung H., Rudge J. (2017). Best practices to prevent transmission and control outbreaks of hand, foot, and mouth disease in childcare facilities: a systematic review. Hong Kong Med. J. 23 177&#x2013;190. 10.12809/hkmj166098</Citation><ArticleIdList><ArticleId IdType="doi">10.12809/hkmj166098</ArticleId><ArticleId IdType="pubmed">28302925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L. Y., Huang L. M., Gau S. S., Wu Y. Y., Hsia S. H., Fan T. Y., et al. (2007). Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 356 1226&#x2013;1234. 10.1056/NEJMoa065954</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B. H., Phuektes P., Sanders S. A., Nicholls P. K., McMinn P. C. (2008). The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 89 1622&#x2013;1632. 10.1099/vir.0.83676-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M., Wang X., Wang Q., Wang Y., Lin J., Sun Y., et al. (2014). Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5 692&#x2013;703. 10.1007/s13238-014-0087-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaseelan S., Wong K. Z., Min N., Sun J., Ismail N. K. B. M., Tan Y. J., et al. (2019). Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection. Sci. Transl. Med. 11:eaar5759. 10.1126/scitranslmed.aar5759</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aar5759</ArticleId><ArticleId IdType="pubmed">31666401</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. C., Liu C. C., Chang Y. C., Chen C. Y., Wang S. T., Yeh T. F. (1999). Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341 936&#x2013;942. 10.1056/nejm199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M. C., Wang S. M., Hsu Y. W., Lin H. C., Chi C. Y., Liu C. C. (2006). Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 118 e1785&#x2013;e1788. 10.1542/peds.2006-1547</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-1547</ArticleId><ArticleId IdType="pubmed">17116698</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Wang Y. F., Yu C. K., Su I. J., Wang J. R. (2012). Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 422 132&#x2013;143. 10.1016/j.virol.2011.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Q. J., Chen X. Y., Li Z., Xu J. J., Xu Z. G., Duan Z. L., et al. (2016). Comparative genomic analysis of enterovirus 71 revealed six new potential neurovirulence-associated sites. Biomed. Environ. Sci. 29 767&#x2013;772. 10.3967/bes2016.103</Citation><ArticleIdList><ArticleId IdType="doi">10.3967/bes2016.103</ArticleId><ArticleId IdType="pubmed">27927278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. (2020). Cellular receptors for enterovirus A71. J. Biomed. Sci. 27:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh W. M., Bogich T., Siegel K., Jin J., Chong E. Y., Tan C. Y., et al. (2016). The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis. Pediatr. Infect. Dis. J. 35 e285&#x2013;e300. 10.1097/INF.0000000000001242</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001242</ArticleId><ArticleId IdType="pmc">PMC5130063</ArticleId><ArticleId IdType="pubmed">27273688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Ye X., Shi J., Wang X., Liu Q., Huang Z. (2015). Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 89 12084&#x2013;12095. 10.1128/JVI.02189-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q. Y., Wang Y., Bian L., Xu M., Liang Z. (2016). EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev. Vaccines 15 599&#x2013;606. 10.1586/14760584.2016.1138862</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Wang Y., Yao X., Bian L., Wu X., Xu M., et al. (2014). Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum. Vaccin. Immunother. 10 360&#x2013;367. 10.4161/hv.27087</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K., Nishimura Y., Abo M., Wakita T., Shimizu H. (2011). Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J. Gen. Virol. 92 287&#x2013;291. 10.1099/vir.0.022418-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassef C., Ziemer C., Morrell D. S. (2015). Hand-foot-and-mouth disease: a new look at a classic viral rash. Curr. Opin. Pediatr. 27 486&#x2013;491. 10.1097/MOP.0000000000000246</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000246</ArticleId><ArticleId IdType="pubmed">26087425</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Poh C. L., Chow V. T. (2002). Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). Microbiol. Immunol. 46 801&#x2013;808. 10.1111/j.1348-0421.2002.tb02767.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2002.tb02767.x</ArticleId><ArticleId IdType="pubmed">12516778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Tijsma A., Mirabelli C., Baggen J., Wahedi M., Franco D., et al. (2019). Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence. Emerg. Microbes Infect. 8 1076&#x2013;1085. 10.1080/22221751.2019.1644142</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1644142</ArticleId><ArticleId IdType="pmc">PMC6711088</ArticleId><ArticleId IdType="pubmed">31339457</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng S., Zhao S. Y., Wei Y., Shao Q. M., Jiang M. Y., Cui D. W., et al. (2013). [Observation on virus shedding periods of enterovirus-71 and coxsackievirus A 16 monitored by nucleic acids determination in stool samples of children with hand, foot and mouth disease]. Zhonghua Er Ke Za Zhi 51 787&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">24406235</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I. H., Yeo H., Sessions O. M., Yan B. J., Libau E. A., Howe J. L., et al. (2016). Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 6:36983. 10.1038/srep36983</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio C. B., Xu Y., Ng Q., Meng T., Chow V. T., Chua K. B. (2016). Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). Emerg. Microbes Infect. 5:e60. 10.1038/emi.2016.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.56</ArticleId><ArticleId IdType="pmc">PMC4932649</ArticleId><ArticleId IdType="pubmed">27329847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li Y. (2019). Recent progress on functional genomics research of enterovirus 71. Virol. Sin. 34 9&#x2013;21. 10.1007/s12250-018-0071-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhu C., Bao W., Zhao K., Niu J., Yu X. F., et al. (2012). Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One 7:e32405. 10.1371/journal.pone.0032405</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. F., Chou C. T., Lei H. Y., Liu C. C., Wang S. M., Yan J. J., et al. (2004). A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78 7916&#x2013;7924. 10.1128/JVI.78.15.7916-7924.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., He D., Li Z., Zheng J., Yang L., Yu M., et al. (2014). Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics 4 498&#x2013;513. 10.7150/thno.7457</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.7457</ArticleId><ArticleId IdType="pmc">PMC3964443</ArticleId><ArticleId IdType="pubmed">24669278</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., He D., Yang L., Li Z., Ye X., Yu H., et al. (2015). A Broadly cross-protective vaccine presenting the neighbouring epitopes within the VP1 GH loop and VP2 EF loop of Enterovirus 71. Sci. Rep. 5:12973. 10.1038/srep12973</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep12973</ArticleId><ArticleId IdType="pmc">PMC4525384</ArticleId><ArticleId IdType="pubmed">26243660</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Ma S., Zhu L., Huang Z., Chen L., Xu Y., et al. (2017). Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model. Antiviral Res. 137 67&#x2013;75. 10.1016/j.antiviral.2016.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.11.008</ArticleId><ArticleId IdType="pubmed">27864074</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E. J., Shin Y. J., Kim J. H., Kim T. G., Chang S. Y. (2017). Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 6 4&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., McMinn P. (2012). A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. J. Gen. Virol. 93 1935&#x2013;1940. 10.1099/vir.0.043893-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043893-0</ArticleId><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., Phuektes P., McMinn P. (2012). A reverse genetic study of the adaptation of human enterovirus 71 to growth in Chinese hamster ovary cell cultures. Virus Res. 165 151&#x2013;156. 10.1016/j.virusres.2012.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.02.009</ArticleId><ArticleId IdType="pubmed">22406130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Zhao Y., Kotecha A., Fry E. E., Kelly J. T., Wang X., et al. (2019). Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 4 414&#x2013;419. 10.1038/s41564-018-0319-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0319-z</ArticleId><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>